Igor Milicic Jr.
Story Poster
42:45
Reed Report: SEC Unfiltered's Dave Schumate previews A&M at Florida
1 mo ago by Luke Evangelist
Texas A&M has just three regular-season games remaining as Buzz Williams & Co. head of Gainesville for a Saturday night clash with No. 3 Florida. On this edition of the Reed Report, Dave Schumate of SEC Unfiltered joined us to breakdown the latest from around the league.
Story Poster
No. 7 A&M seeks to respond vs. No. 6 Tennessee on Saturday morning
2 mo ago by Olin Buchanan
No. 7 Texas A&M saw its five-game winning streak come to a halt earlier this week, and on Saturday morning, the Aggies hope for a good response. However, the challenge will be stiff as No. 6 Tennessee brings its top-rated defense to Reed Arena for an 11 a.m. CT showdown.
Story Poster
Scouting Report: No. 7 Texas A&M vs. No. 6 Tennessee
2 mo ago by Tom Schuberth
It's a Saturday showdown in the Southeastern Conference as No. 7 Texas A&M faces No. 6 Tennessee at Reed Arena in Bryan-College Station. For just the second time in program history, the Aggies are hosting a top-10 men's basketball in Aggieland.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
40:51
Lunch with Liucci: Billy Liucci joins TexAgs Live (Friday, February 21)
2 mo ago by Billy Liucci
TexAgs' co-owner and executive editor Billy Liucci joined TexAgs Live on Friday morning before a busy weekend in Aggieland. Liucci discussed Texas A&M basketball's "black out" game vs. No. 6 Tennessee, baseball's home series with Cal Poly and much more.
Story Poster
8:54
Tennessee insider Josh Ward provides insight on Rick Barnes' No. 6 Vols
2 mo ago by David Nuño
Reed Arena welcomes a top-10 showdown on Saturday as Rick Barnes' No. 6 Tennessee Vols and the No. 7 Fightin' Texas Aggies meet on the hardwood. Tennessee insider Josh Ward joined TexAgs Live to discuss the matchup between the two top-tier defensive squads.
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.